Jinzhu Mao

947 total citations
16 papers, 300 citations indexed

About

Jinzhu Mao is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Jinzhu Mao has authored 16 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Surgery. Recurrent topics in Jinzhu Mao's work include Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), RNA modifications and cancer (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). Jinzhu Mao is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), RNA modifications and cancer (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). Jinzhu Mao collaborates with scholars based in China and United Kingdom. Jinzhu Mao's co-authors include Yi Bai, Fucun Xie, Kai Kang, Xiang Wang, Junyu Long, Haitao Zhao, Jianzhen Lin, Dongxu Wang, Xinting Sang and Xiaobo Yang and has published in prestigious journals such as Frontiers in Immunology, Briefings in Bioinformatics and Frontiers in Oncology.

In The Last Decade

Jinzhu Mao

16 papers receiving 297 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jinzhu Mao China 8 128 116 104 98 74 16 300
Yiming Zhao China 10 131 1.0× 122 1.1× 72 0.7× 64 0.7× 62 0.8× 19 293
Teruhide Ishigame Japan 12 141 1.1× 197 1.7× 101 1.0× 132 1.3× 61 0.8× 36 406
Xin‐Gan Qin China 11 96 0.8× 139 1.2× 114 1.1× 69 0.7× 84 1.1× 25 316
Chan Xiang China 12 95 0.7× 167 1.4× 140 1.3× 124 1.3× 47 0.6× 32 378
Timil Patel United States 6 90 0.7× 114 1.0× 101 1.0× 80 0.8× 82 1.1× 13 311
Xiangbin Wan China 10 122 1.0× 134 1.2× 81 0.8× 100 1.0× 84 1.1× 24 327
Marco Brugia Italy 12 218 1.7× 117 1.0× 128 1.2× 100 1.0× 27 0.4× 31 354
Meiling Zhu China 14 137 1.1× 199 1.7× 156 1.5× 92 0.9× 96 1.3× 25 410
Akira Okimura Japan 8 141 1.1× 112 1.0× 82 0.8× 49 0.5× 67 0.9× 28 290

Countries citing papers authored by Jinzhu Mao

Since Specialization
Citations

This map shows the geographic impact of Jinzhu Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinzhu Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinzhu Mao more than expected).

Fields of papers citing papers by Jinzhu Mao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinzhu Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinzhu Mao. The network helps show where Jinzhu Mao may publish in the future.

Co-authorship network of co-authors of Jinzhu Mao

This figure shows the co-authorship network connecting the top 25 collaborators of Jinzhu Mao. A scholar is included among the top collaborators of Jinzhu Mao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinzhu Mao. Jinzhu Mao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Pan, Wei‐Fong, Jinzhu Mao, Jing Cheng, et al.. (2025). The organic acid metabolites of Bifidobacterium longum subsp. iuvenis alleviate ultraviolet irradiation-induced photoaging. Microbiological Research. 294. 128100–128100. 1 indexed citations
2.
Mao, Jinzhu, Na Du, Yuanyuan Jia, et al.. (2024). Case report: Treatment of psoriasiform dermatitis in patients with malignancy. Frontiers in Medicine. 11. 1363405–1363405. 2 indexed citations
3.
Zhou, Qianqian, et al.. (2023). A Case of Paradoxical Reactions to Biologic Therapy for Psoriasis. Clinical Cosmetic and Investigational Dermatology. Volume 16. 1493–1497. 4 indexed citations
4.
Mao, Jinzhu, et al.. (2023). A case of toxic epidermal necrolysis associated with lenvatinib and sintilimab therapy for intrahepatic cholangiocarcinoma. Journal of International Medical Research. 51(5). 3639234484–3639234484. 6 indexed citations
5.
Li, Qifan, et al.. (2022). HSF1 expression in tumor-associated macrophages promotes tumor cell proliferation and indicates poor prognosis in esophageal squamous cell carcinoma. Clinical & Translational Oncology. 25(6). 1682–1689. 7 indexed citations
6.
Lin, Jianzhen, Songhui Zhao, Dongxu Wang, et al.. (2021). Targeted Next-Generation Sequencing Combined With Circulating-Free DNA Deciphers Spatial Heterogeneity of Resected Multifocal Hepatocellular Carcinoma. Frontiers in Immunology. 12. 673248–673248. 6 indexed citations
7.
Xu, Yang, Ying Hu, Keyan Yang, et al.. (2021). Cell-free DNA copy number variations predict efficacy of immune checkpoint inhibitor-based therapy in hepatobiliary cancers. Journal for ImmunoTherapy of Cancer. 9(5). e001942–e001942. 29 indexed citations
8.
Wang, Dongxu, Xu Yang, Junyu Long, et al.. (2021). The Efficacy and Safety of Apatinib Plus Camrelizumab in Patients With Previously Treated Advanced Biliary Tract Cancer: A Prospective Clinical Study. Frontiers in Oncology. 11. 646979–646979. 32 indexed citations
9.
Mao, Jinzhu, Xu Yang, Jianzhen Lin, et al.. (2021). Apatinib as non-first-line treatment in patients with Intrahepatic Cholangiocarcinoma. Journal of Cancer. 12(5). 1555–1562. 12 indexed citations
10.
Xiao, Jianchun, Jinzhu Mao, & Binglu Li. (2020). Clinical Characteristics and Treatment of Intra-abdominal Aggressive Fibromatosis: A Retrospective Study of 16 Patients. Frontiers in Medicine. 7. 2–2. 5 indexed citations
11.
Long, Junyu, Shan Huang, Yi Bai, et al.. (2020). Transcriptional landscape of cholangiocarcinoma revealed by weighted gene coexpression network analysis. Briefings in Bioinformatics. 22(4). 47 indexed citations
12.
Zhang, Xinmu, Xin Nie, Junyu Long, et al.. (2020). Expression of p42.3 in non-small cell lung cancer. Annals of Translational Medicine. 8(13). 819–819. 4 indexed citations
13.
Kang, Kai, Fucun Xie, Jinzhu Mao, Yi Bai, & Xiang Wang. (2020). Significance of Tumor Mutation Burden in Immune Infiltration and Prognosis in Cutaneous Melanoma. Frontiers in Oncology. 10. 573141–573141. 76 indexed citations
14.
Xie, Fucun, Yi Bai, Xu Yang, et al.. (2020). Comprehensive analysis of tumour mutation burden and the immune microenvironment in hepatocellular carcinoma. International Immunopharmacology. 89(Pt A). 107135–107135. 23 indexed citations
15.
Long, Junyu, Jianping Xiong, Yi Bai, et al.. (2019). Construction and Investigation of a lncRNA-Associated ceRNA Regulatory Network in Cholangiocarcinoma. Frontiers in Oncology. 9. 649–649. 32 indexed citations
16.
Bai, Yi, Fucun Xie, Fei Miao, et al.. (2019). The diagnostic and prognostic role of RhoA in hepatocellular carcinoma. Aging. 11(14). 5158–5172. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026